Cargando…
Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials
BACKGROUND: Colchicine has been used an effective anti-inflammatory drug to treat gout diseases. Owing to its pharmacodynamic of inhibiting interleukins, it has been repurposed to target the cytokine storm post-SARS-CoV-2 invasion. The goal of this meta-analysis was to evaluate the safety profile of...
Autores principales: | Yasmin, Farah, Najeeb, Hala, Moeed, Abdul, Hassan, Wardah, Khatri, Mahima, Asghar, Muhammad Sohaib, Naveed, Ahmed Kunwer, Ullah, Waqas, Surani, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982874/ https://www.ncbi.nlm.nih.gov/pubmed/35381033 http://dx.doi.org/10.1371/journal.pone.0266245 |
Ejemplares similares
-
Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022) -
Efficacy and safety of finerenone in chronic kidney disease and type 2 diabetes patients: a systematic review and meta-analysis
por: Yasmin, Farah, et al.
Publicado: (2023) -
Novel drug delivery systems for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022) -
COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
por: Yasmin, Farah, et al.
Publicado: (2021) -
Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
por: Najeeb, Hala, et al.
Publicado: (2022)